期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Fibroblast Growth Factor 19 Induced Changes in Non-malignant Cholangiocytes
1
作者 Jiaqi Yang David Sontag +1 位作者 sam kung Gerald Y.Minuk 《Journal of Clinical and Translational Hepatology》 SCIE 2021年第6期909-916,共8页
Background and Aims:Fibroblast growth factor(FGF)19 has been implicated in the pathogenesis of murine hepatocellular carcinoma.Whether it plays a role in the development or course of human cholangiocarcinoma remains t... Background and Aims:Fibroblast growth factor(FGF)19 has been implicated in the pathogenesis of murine hepatocellular carcinoma.Whether it plays a role in the development or course of human cholangiocarcinoma remains to be determined.The aim of this study was to determine whether prolonged exposure to FGF19 results in the transformation of non-malignant human cholangiocytes into cells with malignant features.Methods:Human SV-40 transfected non-malignant H69 cholangiocytes were cultured with FGF19(0-50 ng/mL)for 6 weeks,followed by 6 weeks with medium alone.Cell proliferation,invasion,stem cell surface markers,oncofetoprotein expression,state of differentiation,epithelial-mesenchymal transition(EMT)and interleukin(IL)-6 expression were documented at various time intervals throughout the 12-week period.Results:FGF19 exposure was associated with significant increases in cell proliferation,de-differentiation,EMT and IL-6 expression.However,each of these effects returned to baseline or control values during the 6-week FGF19 free follow-up period.The remaining cell properties remained unaltered.Conclusions:Six weeks of FGF19 exposure did not result in the acquisition of permanent malignant features in non-malignant,human cholangiocytes. 展开更多
关键词 Fibroblast growth factor 19 CHOLANGIOCYTES CHOLANGIOCARCINOMA Farnisoid x receptor Obetcholic acid
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部